loading
Schlusskurs vom Vortag:
$4.73
Offen:
$4.74
24-Stunden-Volumen:
98,203
Relative Volume:
0.85
Marktkapitalisierung:
$2.42M
Einnahmen:
$9.00M
Nettoeinkommen (Verlust:
$-7.21M
KGV:
-9.6182
EPS:
-0.55
Netto-Cashflow:
$-7.59M
1W Leistung:
+13.16%
1M Leistung:
-40.93%
6M Leistung:
-96.02%
1J Leistung:
-98.53%
1-Tages-Spanne:
Value
$4.74
$5.50
1-Wochen-Bereich:
Value
$4.40
$5.50
52-Wochen-Spanne:
Value
$4.365
$2,655.00

Applied Dna Sciences Inc Stock (APDN) Company Profile

Name
Firmenname
Applied Dna Sciences Inc
Name
Telefon
631-240-8800
Name
Adresse
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Name
Mitarbeiter
48
Name
Twitter
@APDN
Name
Nächster Verdiensttermin
2024-08-08
Name
Neueste SEC-Einreichungen
Name
APDN's Discussions on Twitter

Vergleichen Sie APDN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
APDN
Applied Dna Sciences Inc
5.29 2.42M 9.00M -7.21M -7.59M -0.55
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
397.88 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
196.39 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
523.92 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
115.56 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
154.73 27.64B 15.50B 1.33B 2.16B 7.34

Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-02-12 Eingeleitet ROTH Capital Buy
2021-01-14 Bestätigt H.C. Wainwright Buy
2020-12-18 Bestätigt H.C. Wainwright Buy
2020-07-20 Bestätigt H.C. Wainwright Buy
2020-07-02 Eingeleitet H.C. Wainwright Buy
2016-11-14 Bestätigt Maxim Group Buy
2016-05-13 Bestätigt Maxim Group Buy
2015-10-08 Bestätigt Maxim Group Buy
2015-05-26 Eingeleitet The Benchmark Company Speculative Buy
2015-02-10 Bestätigt Maxim Group Buy
2015-01-13 Eingeleitet Maxim Group Buy
Alle ansehen

Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten

pulisher
Jun 18, 2025

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - The Tennessean

Jun 18, 2025
pulisher
Jun 18, 2025

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward | APDN Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com India

Jun 17, 2025
pulisher
Jun 17, 2025

Applied DNA Sciences names Judy Murrah as new chairperson and CEO By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

APDN Leadership Transition: Judy Murrah Appointed CEO | APDN Sto - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied DNA Sciences Appoints Harvard MBA Veteran Judy Murrah as CEO, Founder Retires After Two Decades - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Knoxville News Sentinel

Jun 16, 2025
pulisher
Jun 16, 2025

Applied DNA Sciences (APDN) to Restart Quarterly Investor Calls | APDN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August | APDN Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Applied DNA Sciences Returns to Regular Earnings Updates: What Investors Should Know About New Schedule - Stock Titan

Jun 16, 2025
pulisher
Jun 12, 2025

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Knoxville News Sentinel

Jun 12, 2025
pulisher
Jun 10, 2025

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q3 2024 Earnings Call Transcript - MSN

Jun 10, 2025
pulisher
Jun 08, 2025

Applied DNA Sciences fails to secure shareholder vote - MSN

Jun 08, 2025
pulisher
Jun 06, 2025

applied dna sciences faces nasdaq delisting due to bid price rule - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

Applied DNA Sciences Faces Nasdaq Delisting Hearing - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Top Premarket Gainers - MarketScreener

Jun 06, 2025
pulisher
Jun 05, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 - Livingston Daily

Jun 05, 2025
pulisher
Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025
pulisher
Jun 03, 2025

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Knoxville News Sentinel

Jun 03, 2025
pulisher
Jun 02, 2025

Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested - The Globe and Mail

Jun 02, 2025
pulisher
May 31, 2025

Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World

May 31, 2025
pulisher
May 31, 2025

APDN stock plunges to 52-week low of $0.32 amid market challenges By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

APDN Trading Halted as Market Awaits Significant Announcement | APDN Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Applied DNA announces 1-for-15 reverse stock split - MSN

May 30, 2025
pulisher
May 29, 2025

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 | APDN Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Applied DNA Sciences (APDN) to Implement 1-for-15 Reverse Stock - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Applied DNA Sciences Approves Reverse Stock Split - TipRanks

May 29, 2025
pulisher
May 29, 2025

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 | APDN Stock News - GuruFocus

May 29, 2025

Finanzdaten der Applied Dna Sciences Inc-Aktie (APDN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$179.43
price down icon 0.19%
diagnostics_research WAT
$342.63
price up icon 0.96%
diagnostics_research LH
$261.88
price up icon 0.19%
$171.86
price up icon 0.51%
diagnostics_research MTD
$1,153.93
price up icon 0.74%
diagnostics_research IQV
$154.73
price up icon 0.08%
Kapitalisierung:     |  Volumen (24h):